Experience:
No experience
Employment Type:
Full time
Posted:
10/2/2017
Job Category:
Transportation
See more jobs for students and recent grads who studied:
Lead BIA Operations - Web Id: 29375
Bristol-Myers Squibb | Newark, New Jersey
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company
Share

Job Description

Reference # 9455 

Lead BIA Operations & GMS Analytics

Requires Master's (or foreign equivalent.) in Business Administrative, Engineering or related +7 years’ experience. Use Experience with Strategic Management Consulting, Analytics, Master Data Management, Data Quality; Core Software including SAS, Advanced Excel; Bus Transformation/Change Management; Engineering /Manufacturing experience to drive day-to-day operations & planning processes of Worldwide Analytics Organization inclusive of: R&D, Commercial, Corporate, HR & GMS. 25% of domestic & international travel required. Bristol-Myers Squibb Company. Lawrenceville, NJ. Full Time. 

 

Web Id: 29375


recblid g1vftf1e4tzkf0i6gwzb21c8rhlkoo

About Bristol-Myers Squibb

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company had two segments: Pharmaceuticals and Nutritionals. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The Nutritionals segment consists of Mead Johnson Nutritionals (Mead Johnson), primarily an infant formula and children's nutritionals business. In June 2008, BMS acquired Kosan Biosciences, Inc., a developer of oncology products. In August 2008, the Company completed the divestiture of its ConvaTec business to Cidron Healthcare Limited, an affiliate of Nordic Capital Fund VII and Avista. In December 2008, BMS completed the sale of its brand business in Egypt to GlaxoSmithKline. In July 2009, the Company's branded generics business, which comprises a portfolio of 13 branded pharmaceuticals was acquired by GlaxoSmithKline plc.

This company profile was created by AfterCollege and is about Bristol-Myers Squibb. This page is not endorsed by or affiliated with Bristol-Myers Squibb. For questions regarding company profiles, please email: care@aftercollege.com.